Antibody for assay of ADAMTS13 activity and method of activity assay

Details for Australian Patent Application No. 2006213411 (hide)

Owner Alfresa Pharma Corporation

Inventors Kato, Seiji; Fujimura, Yoshihiro; Matsumoto, Masanori; Hiura, Hisahide

Agent Spruson & Ferguson

Pub. Number AU-B-2006213411

PCT Pub. Number WO2006/085441

Priority 2005-036612 14.02.05 JP; 2005-157530 30.05.05 JP

Filing date 26 January 2006

Wipo publication date 17 August 2006

Acceptance publication date 23 September 2010

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 15/07 (2006.01) Mutation or genetic engineering - Human cells

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/085441 Priority application(s): WO2006/085441

2 September 2010 Assignment before Grant

  Japan Clinical Laboratories, Inc. The application has been assigned to Alfresa Pharma Corporation

23 September 2010 Application Accepted

  Published as AU-B-2006213411

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006213420-Device, method, and system for module level network supervision

2006213410-Core, rotor, motor, and compressor